Replies to post #1952 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

Are you asking about EDP-514? The phase-1b data, so far, look fine.

Is a 1 log decrease going to be sufficient to be a good anti-HBV drug? I assume ENTA won't be using EDP-514 as a single drug treatment. I guess we have to see how the 800mg dosage does.